E. P. Krenning

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors

S. Severi, S. Severi, I. Drozdov, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: Dynamic endocrine studies and treatment with the somatostatin analogue octreotide

E. Krenning, H. Koppeschaar, J. Thijssen, 1994, Journal of endocrinological investigation.

PLACE OF RADIOACTIVE IODINE IN TREATMENT OF THYROTOXICOSIS

E. Krenning, G. Hennemann, K. Sankaranarayanan, 1986, The Lancet.

Octreotide‐scintigraphy is a disease‐activity parameter in Graves' ophthalmopathy

M. Gerding, L. Koornneef, E. V. van Royen, 1999, Clinical endocrinology.

Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status

S. Severi, I. Drozdov, V. Ambrosini, 2015, European Journal of Nuclear Medicine and Molecular Imaging.